Cansino Biologics

Developer of vaccines for the treatment of infectious diseases

placeTianjin, Tianjin, China calendar_todayFounded 2009 groups2,291 employees language cansinotech.com

Investor mix

11 investors on record; lead investors include SDIC Innovation.

Investor typeCountShare
Venture capital436%
Private equity327%
Other / undisclosed436%
Coming soon